- £187.52bn
- £208.44bn
- $45.81bn
- 80
- 12
- 97
- 70
REG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - EMA validates Dato-DXd MAAs for NSQ NSCLC and BC
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Voydeya recommended for EU approval
AnnouncementREG - AstraZeneca PLC - Acquisition of Gracell completed
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - AstraZeneca prices a $5bn bond offering
AnnouncementREG - AstraZeneca PLC - Filing of Form 20-F with SEC
AnnouncementREG - AstraZeneca PLC - Annual Financial Report
AnnouncementREG - AstraZeneca PLC - AstraZeneca completes acquisition of Icosavax
AnnouncementREG - AstraZeneca PLC - FDA accepts Dato-DXd BLA for nonsquamous NSCLC
AnnouncementREG - AstraZeneca PLC - Tagrisso plus chemo approved in US for lung cancer
AnnouncementREG - AstraZeneca PLC - Tagrisso improved PFS in Stage III lung cancer
AnnouncementREG - AstraZeneca PLC - Final Results
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - AstraZeneca acquires Gracell
AnnouncementREG - AstraZeneca PLC - Wainua (eplontersen) granted first US FDA approval
Announcement